RESMED INC. COMMON STOCK

ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions

14 Jun 2022 01:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference

07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference

01 Jun 2022 08:00:02 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference

25 May 2022 08:00:01 By Nasdaq GlobeNewswire

Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study

18 May 2022 15:05:00 By Nasdaq GlobeNewswire

ResMed Announces Leadership Change

05 May 2022 15:05:01 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022

28 Apr 2022 15:05:02 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 24th Annual Macquarie Australia Conference

27 Apr 2022 15:05:00 By Nasdaq GlobeNewswire

ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022

07 Apr 2022 15:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

17 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference

10 Mar 2022 08:00:10 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Citi Healthcare Conference

16 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer

01 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022

06 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference

03 Jan 2022 08:00:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference

30 Dec 2021 08:00:00 By Nasdaq GlobeNewswire

ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors

19 Nov 2021 08:00:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference

03 Nov 2021 08:00:01 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022

28 Oct 2021 15:05:01 By Nasdaq GlobeNewswire

ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021

07 Oct 2021 15:05:00 By Nasdaq GlobeNewswire